Skip to main content
FinSpry Logo
FinSpry
CCCC logo
CCCC
(NASDAQ)
C4 Therapeutics, Inc.
$3.44-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

C4 Therapeutics (CCCC) Stock Price & Financial Analysis

C4 Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.42 - $3.54
52-Week High$5.17
52-Week Low$1.69
Open$3.54
Volume1.44M
Average Volume (3M)2.31M
Market Cap433.70M
Shares Outstanding126.07M
Price to Sales (P/S)12.44
Price to Book (P/B)1.85
EV/EBITDA-3.98
Revenue (TTM)34.86M
Net Income (TTM)-103.80M
Free Cash Flow (TTM)-96.02M
EPS (TTM)$-1.07
Profit Margin-297.76%
Operating Margin-326.56%
Return on Equity (ROE)-44.31%
Debt to Equity0.25
50-Day MA$3.88
200-Day MA$3.05
52-Week Change28.36%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About C4 Therapeutics

What is the current stock price for CCCC?

As of the latest trading session, CCCC stock trades at $3.44. The 52-week range is $1.69–$5.17, with a day range of $3.42–$3.54.

What is the P/E ratio for CCCC?

The P/E ratio (Price-to-Earnings) for CCCC is shown in the Key Statistics section. This valuation metric helps compare C4 Therapeutics, Inc. to industry peers.

Does CCCC pay dividends?

C4 Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CCCC?

Based on 1 analyst, the consensus for CCCC is Buy.

What is the market cap of CCCC?

C4 Therapeutics's market capitalization is $433.7M, classifying it as a small-cap company. C4 Therapeutics operates in the Healthcare sector within the Biotechnology industry.